Matches in SemOpenAlex for { <https://semopenalex.org/work/W1485654772> ?p ?o ?g. }
- W1485654772 endingPage "520" @default.
- W1485654772 startingPage "513" @default.
- W1485654772 abstract "Aims To investigate the rate of excretion and routes of metabolism of tolcapone, a novel inhibitor of catechol-O-methyltransferase (COMT). Methods Six healthy male volunteers were given 200 mg [14C]-tolcapone (approximately 50 μCi) orally. To assess excretion balance and to identify metabolites, urine and faeces were collected before administration and until radioactivity fell below 75 d min−1 ml−1 (urine) and 100 d min−1 mg−1 (faeces). Blood samples were collected frequently before and after administration to determine plasma radioactivity, to identify tolcapone metabolites and to measure plasma tolcapone and its methylated derivative 3-O-methyltolcapone (3-OMT). Results The mean proportion of the dose excreted in urine was 57.3% and in faeces 40.5%. Excretion was almost complete (more than 95%) in all participants after 9 days. The major early metabolite present in plasma was the 3-O-β,d-glucuronide conjugate, which was detectable within 2 h after dosing. The major late metabolite in plasma was 3-OMT. The 3-O-β,d-glucuronide was also the most abundant metabolite in urine and faeces, accounting for 27% and 33%, respectively, of the total radioactivity excreted by these routes and for 26% of the original dose. Reduction of the nitro moiety yields an amine derivative, detected in both urine and faeces, with subsequent modifications, such as acetylation of the amine group and conjugation with glucuronic acid or sulphate, or both. Oxidative reactions due to cytochrome P450 enzymes are of small significance, as is 3-O-methylation by COMT. Conclusions Tolcapone is almost completely metabolized and excreted in urine and faeces (only 0.5% of tolcapone was excreted unchanged); glucuronidation is the most important route of metabolism. The relatively long duration of excretion is caused by the long half-life of 3-OMT." @default.
- W1485654772 created "2016-06-24" @default.
- W1485654772 creator A5003517337 @default.
- W1485654772 creator A5031293607 @default.
- W1485654772 creator A5040662613 @default.
- W1485654772 creator A5075004709 @default.
- W1485654772 date "1999-10-01" @default.
- W1485654772 modified "2023-10-14" @default.
- W1485654772 title "Metabolism and excretion of tolcapone, a novel inhibitor of catechol-<i>O</i> -methyltransferase" @default.
- W1485654772 cites W1862343335 @default.
- W1485654772 cites W1973734151 @default.
- W1485654772 cites W1975171688 @default.
- W1485654772 cites W2016013480 @default.
- W1485654772 cites W2027142021 @default.
- W1485654772 cites W2038996343 @default.
- W1485654772 cites W2043729686 @default.
- W1485654772 cites W2051557976 @default.
- W1485654772 cites W2090089396 @default.
- W1485654772 cites W2113689256 @default.
- W1485654772 cites W2134178274 @default.
- W1485654772 cites W2321049536 @default.
- W1485654772 doi "https://doi.org/10.1046/j.1365-2125.1999.00036.x" @default.
- W1485654772 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2014389" @default.
- W1485654772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10583021" @default.
- W1485654772 hasPublicationYear "1999" @default.
- W1485654772 type Work @default.
- W1485654772 sameAs 1485654772 @default.
- W1485654772 citedByCount "83" @default.
- W1485654772 countsByYear W14856547722012 @default.
- W1485654772 countsByYear W14856547722013 @default.
- W1485654772 countsByYear W14856547722014 @default.
- W1485654772 countsByYear W14856547722015 @default.
- W1485654772 countsByYear W14856547722016 @default.
- W1485654772 countsByYear W14856547722017 @default.
- W1485654772 countsByYear W14856547722018 @default.
- W1485654772 countsByYear W14856547722019 @default.
- W1485654772 countsByYear W14856547722020 @default.
- W1485654772 countsByYear W14856547722021 @default.
- W1485654772 countsByYear W14856547722022 @default.
- W1485654772 countsByYear W14856547722023 @default.
- W1485654772 crossrefType "journal-article" @default.
- W1485654772 hasAuthorship W1485654772A5003517337 @default.
- W1485654772 hasAuthorship W1485654772A5031293607 @default.
- W1485654772 hasAuthorship W1485654772A5040662613 @default.
- W1485654772 hasAuthorship W1485654772A5075004709 @default.
- W1485654772 hasBestOaLocation W14856547722 @default.
- W1485654772 hasConcept C10146269 @default.
- W1485654772 hasConcept C104317684 @default.
- W1485654772 hasConcept C126322002 @default.
- W1485654772 hasConcept C134018914 @default.
- W1485654772 hasConcept C180754005 @default.
- W1485654772 hasConcept C181199279 @default.
- W1485654772 hasConcept C185361966 @default.
- W1485654772 hasConcept C185592680 @default.
- W1485654772 hasConcept C2777477808 @default.
- W1485654772 hasConcept C2779186261 @default.
- W1485654772 hasConcept C2779907587 @default.
- W1485654772 hasConcept C2780026642 @default.
- W1485654772 hasConcept C55493867 @default.
- W1485654772 hasConcept C62231903 @default.
- W1485654772 hasConcept C71924100 @default.
- W1485654772 hasConcept C86803240 @default.
- W1485654772 hasConcept C87644729 @default.
- W1485654772 hasConcept C98274493 @default.
- W1485654772 hasConceptScore W1485654772C10146269 @default.
- W1485654772 hasConceptScore W1485654772C104317684 @default.
- W1485654772 hasConceptScore W1485654772C126322002 @default.
- W1485654772 hasConceptScore W1485654772C134018914 @default.
- W1485654772 hasConceptScore W1485654772C180754005 @default.
- W1485654772 hasConceptScore W1485654772C181199279 @default.
- W1485654772 hasConceptScore W1485654772C185361966 @default.
- W1485654772 hasConceptScore W1485654772C185592680 @default.
- W1485654772 hasConceptScore W1485654772C2777477808 @default.
- W1485654772 hasConceptScore W1485654772C2779186261 @default.
- W1485654772 hasConceptScore W1485654772C2779907587 @default.
- W1485654772 hasConceptScore W1485654772C2780026642 @default.
- W1485654772 hasConceptScore W1485654772C55493867 @default.
- W1485654772 hasConceptScore W1485654772C62231903 @default.
- W1485654772 hasConceptScore W1485654772C71924100 @default.
- W1485654772 hasConceptScore W1485654772C86803240 @default.
- W1485654772 hasConceptScore W1485654772C87644729 @default.
- W1485654772 hasConceptScore W1485654772C98274493 @default.
- W1485654772 hasIssue "4" @default.
- W1485654772 hasLocation W14856547721 @default.
- W1485654772 hasLocation W14856547722 @default.
- W1485654772 hasLocation W14856547723 @default.
- W1485654772 hasLocation W14856547724 @default.
- W1485654772 hasOpenAccess W1485654772 @default.
- W1485654772 hasPrimaryLocation W14856547721 @default.
- W1485654772 hasRelatedWork W1851873892 @default.
- W1485654772 hasRelatedWork W1973667133 @default.
- W1485654772 hasRelatedWork W2007345687 @default.
- W1485654772 hasRelatedWork W2040074963 @default.
- W1485654772 hasRelatedWork W2045937169 @default.
- W1485654772 hasRelatedWork W2090888544 @default.
- W1485654772 hasRelatedWork W2095899880 @default.
- W1485654772 hasRelatedWork W2406801323 @default.
- W1485654772 hasRelatedWork W2430409124 @default.